Logo

Schistosomes, Liver Flukes and Helicobacter pylori

Large book cover: Schistosomes, Liver Flukes and Helicobacter pylori

Schistosomes, Liver Flukes and Helicobacter pylori

Publisher: International Agency for Research on Cancer
Number of pages: 279

Description:
This volume Evaluates the carcinogenic risk to humans posed by infection with three schistosoma trematodes, three liver flukes, and the bacterium Helicobacter pylori. These biological agents were selected for evaluation on the basis of evidence suggesting a causal association between infection and the development of human cancers.

Home page url

Download or read it online for free here:
Download link
(22MB, PDF)

Similar books

Book cover: Genetic Susceptibility to Breast and Ovarian CancerGenetic Susceptibility to Breast and Ovarian Cancer
- American College of Medical Genetics
The Guidelines have been prepared to help the primary care provider to participate in the pre- and post-test education and counseling required for every patient contemplating genetic testing for breast and ovarian cancer.
(6525 views)
Book cover: Gastric Carcinoma: New Insights into Current ManagementGastric Carcinoma: New Insights into Current Management
by - InTech
Gastric cancer is the second most common cause of cancer-related death in the world. The book makes an insight into the assessment of premalignant lesions, management of early gastric cancer, risk and protective factors in gastric carcinogenesis.
(6614 views)
Book cover: Ovarian Cancer: The Recognition and Initial ManagementOvarian Cancer: The Recognition and Initial Management
- National Collaborating Centre for Cancer
These clinical guidelines review a number of clinical questions that involve the detection, diagnosis and initial management of ovarian cancer and which focus on areas of uncertainty or where there is a wide variation in clinical practice.
(6622 views)
Book cover: Non-Hodgkin's Lymphoma: Diagnosis and ManagementNon-Hodgkin's Lymphoma: Diagnosis and Management
- National Institute for Health and Care Excellence
This guideline aims to facilitate standardisation of practice in treating non-Hodgkin's lymphoma. But because of the rapid development of new therapies as a result of improved understanding of the disease, continual re-evaluation will be essential.
(3865 views)